ES2194007T3 - Tetrahidrobenzxo(cd)indoles 6-sustituidos. - Google Patents

Tetrahidrobenzxo(cd)indoles 6-sustituidos.

Info

Publication number
ES2194007T3
ES2194007T3 ES91307531T ES91307531T ES2194007T3 ES 2194007 T3 ES2194007 T3 ES 2194007T3 ES 91307531 T ES91307531 T ES 91307531T ES 91307531 T ES91307531 T ES 91307531T ES 2194007 T3 ES2194007 T3 ES 2194007T3
Authority
ES
Spain
Prior art keywords
indoles
tetrahydrobenzxo
replaced
tetrahidrobenz
reliefed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91307531T
Other languages
English (en)
Inventor
Michael Edward Flaugh
Michael John Martinelli
John Mehnert Schaus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2194007T3 publication Critical patent/ES2194007T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A CIERTOS 4-AMINO-6-SUSTITUIDO -TETRAHIDROBENZ[CD] INDOLES Y SU USO EN EL TRATAMIENTO DE TRANSTORNOS QUE PUEDEN ALIVIARSE MODIFICANDO LA FUNCION RECEPTORA DE 5-HT A.
ES91307531T 1990-08-15 1991-08-14 Tetrahidrobenzxo(cd)indoles 6-sustituidos. Expired - Lifetime ES2194007T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56799090A 1990-08-15 1990-08-15
US07/725,175 US5229409A (en) 1990-08-15 1991-07-03 6-substituted-tetrahydrobenz[cd]indoles

Publications (1)

Publication Number Publication Date
ES2194007T3 true ES2194007T3 (es) 2003-11-16

Family

ID=27074632

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91307531T Expired - Lifetime ES2194007T3 (es) 1990-08-15 1991-08-14 Tetrahidrobenzxo(cd)indoles 6-sustituidos.

Country Status (25)

Country Link
US (1) US5229409A (es)
EP (1) EP0471576B1 (es)
JP (1) JP3034085B2 (es)
KR (1) KR100221159B1 (es)
CN (1) CN1031999C (es)
AT (1) ATE234285T1 (es)
AU (1) AU648575B2 (es)
BR (1) BR9103481A (es)
CA (1) CA2049212C (es)
CZ (1) CZ280605B6 (es)
DE (1) DE69133212T2 (es)
DK (1) DK0471576T3 (es)
ES (1) ES2194007T3 (es)
FI (1) FI102677B (es)
HU (1) HU220757B1 (es)
IE (1) IE912878A1 (es)
IL (1) IL99148A (es)
MX (1) MX9100646A (es)
MY (1) MY106764A (es)
NO (1) NO176020C (es)
NZ (1) NZ239333A (es)
PT (1) PT98640B (es)
RU (1) RU2073672C1 (es)
TW (1) TW197422B (es)
YU (1) YU48058B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
TW219933B (es) * 1990-02-26 1994-02-01 Lilly Co Eli
US5340838A (en) * 1990-05-04 1994-08-23 Eli Lilly And Company Method of inhibiting gastric acid secretion with 2-phenylcyclopropylamines
US5089517A (en) * 1990-08-03 1992-02-18 The Board Of Trustees Of The Leland Stanford Junior University Neuroprotection by indolactam v and derivatives thereof
US5229410A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-hexahydrobenz[cd]indoles
CZ285762B6 (cs) * 1993-06-10 1999-11-17 Eli Lilly And Company Farmaceutický prostředek vhodný pro prevenci dávení a zvracení a pro ošetřování sexuální dysfunkce savců a jeho použití
US5385928A (en) * 1994-05-18 1995-01-31 Eli Lilly And Company Tetrahydrobenz [CD] indazoles, compositions and use

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE517732C (de) * 1927-10-27 1931-02-09 Then Rudolf Faerbekufe mit einem drehbaren, trommelartigen Rahmen fuer die auf aus-wechselbaren Faerbestoecken aufgehaengten Waren, insbesondere Struempfe
US3194811A (en) * 1963-09-05 1965-07-13 Merck & Co Inc Aroyl-benzindolyl acids
BE755270A (fr) * 1969-08-27 1971-02-25 Sandoz Sa Nouveaux derives du benzo(cd)indole, leur preparation et medicaments contenant ces derives
BE757879A (fr) * 1969-10-24 1971-04-22 Sandoz Sa Derives du benzo(cd)indole, leur preparation et medicaments contenant ces derives
FI206974A (es) * 1973-07-16 1975-01-17 Sandoz Ag
US4110339A (en) * 1977-11-25 1978-08-29 Eli Lilly And Company 4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
US4282240A (en) * 1979-11-23 1981-08-04 Merck & Co., Inc. Amino substituted tetrahydrobenzindoles
FR2510111A1 (fr) * 1981-07-24 1983-01-28 Roussel Uclaf Nouveaux derives du piperidin-3-yl indole, leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
FR2522658A1 (fr) * 1982-03-05 1983-09-09 Roussel Uclaf Application a titre de medicaments de derives du trans 4-amino benz (c,d) indol-5-ol ainsi que de leurs sels, compositions les renfermant, nouveaux derives et leur procede de preparation
DE3346573A1 (de) * 1983-12-23 1985-07-04 Troponwerke GmbH & Co KG, 5000 Köln 1,3,4,5-tetrahydrobenz(c,d)indole, ein verfahren zu ihrer herstellung und ihre verwendung
IL74222A (en) * 1984-02-06 1988-07-31 Lilly Co Eli 6-substituted-4-dialkylamino tetrahydrobenz(c,d)indoles,their preparation and pharmaceutical compositions comprising them
US4983622A (en) * 1984-02-06 1991-01-08 Eli Lilly And Company 6-substituted-4-dialkylaminotetrahydrobenz(c,d)indoles
US4576959A (en) * 1984-02-06 1986-03-18 Eli Lilly And Company 6-Substituted-4-dialkylaminotetrahydrobenz[c,d]indoles
CA1266482A1 (en) * 1984-05-24 1990-03-06 Carl Kaiser 6-oxygenated-1,3,4,5-tetrahydrobenz(cd)indol-4-amines
DE3525564A1 (de) * 1985-07-15 1987-02-05 Schering Ag Tricyclische verbindungen mit indolstruktur, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
US4745126A (en) * 1987-03-12 1988-05-17 Eli Lilly And Company Method of treating anxiety with tetrahydrobenz[c,d]indole-6-carboxamides
DE3809155A1 (de) * 1988-03-18 1989-09-28 Bayer Ag 1,3,4,5-tetrahydrobenz-(c,d)-indole
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
JPH07103105B2 (ja) * 1989-05-12 1995-11-08 杏林製薬株式会社 インドール誘導体及びその製造方法
US5039820A (en) * 1990-02-26 1991-08-13 Eli Lilly And Company 4-amino-6-iodo-hexahydrobenz(cd)indoles
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion

Also Published As

Publication number Publication date
CN1058961A (zh) 1992-02-26
FI102677B1 (fi) 1999-01-29
NO176020B (no) 1994-10-10
RU2073672C1 (ru) 1997-02-20
DK0471576T3 (da) 2003-12-01
CN1031999C (zh) 1996-06-12
HU912706D0 (en) 1992-01-28
BR9103481A (pt) 1992-05-12
IE912878A1 (en) 1992-02-26
FI102677B (fi) 1999-01-29
PT98640A (pt) 1992-06-30
YU140491A (sh) 1994-01-20
EP0471576A1 (en) 1992-02-19
EP0471576B1 (en) 2003-03-12
KR100221159B1 (ko) 1999-09-15
FI913835A0 (fi) 1991-08-13
ATE234285T1 (de) 2003-03-15
IL99148A (en) 1995-12-08
HU220757B1 (hu) 2002-05-28
CA2049212C (en) 2003-04-08
NZ239333A (en) 1993-05-26
HUT59094A (en) 1992-04-28
TW197422B (es) 1993-01-01
KR920004347A (ko) 1992-03-27
NO913159D0 (no) 1991-08-13
JPH04230663A (ja) 1992-08-19
MY106764A (en) 1995-07-31
AU648575B2 (en) 1994-04-28
CA2049212A1 (en) 1992-02-16
JP3034085B2 (ja) 2000-04-17
DE69133212T2 (de) 2003-11-20
YU48058B (sh) 1996-10-18
PT98640B (pt) 1999-01-29
NO176020C (no) 1995-01-18
NO913159L (no) 1992-02-17
US5229409A (en) 1993-07-20
MX9100646A (es) 1992-04-01
AU8240691A (en) 1992-02-27
CZ280605B6 (cs) 1996-03-13
DE69133212D1 (de) 2003-04-17
FI913835A (fi) 1992-02-16
CS249491A3 (en) 1992-03-18

Similar Documents

Publication Publication Date Title
MX9709351A (es) Derivados de alfa-hordotionina con alto contenido de treonina.
MX9709352A (es) Derivados de alfa-hortodionina con alto contenido de metionina.
NO912938D0 (no) Fremgangsmaate for samtidig hydrogenering av to farlige organiske utgangsmaterialer.
PT641343E (pt) Derivados de 4-mercaptoacetilamino-¬2|benzazapinona (3) e a sua utilizacao como inibidores de encefalinase
ES2096018T3 (es) Goma gelana para geles no quebradizos.
IT8822556A0 (it) Amplificatore audio integrato con regolazione unificata delle funzioni di "mute" e "stand by" e dei transitori di commutazione.
ES2044662T3 (es) Catalizadores de platino sobre soporte de grafito y su empleo.
DK0706385T3 (da) Anvendelse af isovaleramid som et mildt anxiolytisk og et mildt sedativt middel
ES2194007T3 (es) Tetrahidrobenzxo(cd)indoles 6-sustituidos.
DE69431162T2 (de) Fenbendazolformulierungen
ES2062145T3 (es) 1,8-naftiridinas substituidas.
AU129006S (en) Hitch ball
ATE99303T1 (de) Substituierte 3-amino-chromane.
ES2056876T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
ES1005242U (es) Microscopio simplificado
AU7649891A (en) Heterocyclic-nmda antagonists
ES2154406T3 (es) Sistema gelificante que comprende carragenina y endospermo de coco.
SE9604781L (sv) Hjälmanordning
ATE51520T1 (de) Kosmetikum.
ES2165020T3 (es) Monohidrato de famciclovir.
DE58907569D1 (de) Isomere Trimethylbicyclo[4.3.0]nonan-Derivate.
ES2004489A4 (es) Gametocidas de piridina.
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
AU111906S (en) Sinker